epilepsy
Eisai Completes Phase III Trial For Epilepsy Drug
The Phase III clinical trial for Eisai's in-house developed AMPA receptor antagonist Fycompa® has met its primary endpoints in patients with severe seizures.
App Aids Epilepsy Diagnosis
A new smart phone application tested in India and Nepal may help people detect epileptic seizures and get better stroke treatment.
Detect Epileptic Seizures By ‘Hearing’ Brainwaves
A method of converting the brain wave signals of people living with epilepsy into sound has been developed by Australian researchers.
Scientists Find Gene For Hereditary Epilepsy
Researchers have tracked a hereditary gene responsible for a common form of epilepsy known as focal or partial epilepsy.
Eisai Receives Russian Approval For Anti-Epileptic Drug, Zonegran
Eisai Co. Ltd. announced today that it has received Russian regulatory approval for its antiepileptic drug, Zonegran (zonisamide).
SK Biopharmaceuticals Epilepsy Drug Wins Korean Government Funding Support
SK Biopharmaceuticals' lead epilepsy drug, YKP3089, has been awarded funding from the Korean Drug Development Fund.
E.T. Amino Acid From Meteorite Cut Epileptic Seizures In Rats By Half, Study
Researchers at the Albany Medical Center have discovered that an extraterrestrial amino acid from the Murchison meteorite may prevent or reduce the duration of seizures in epilepsy.
Genetic Cause Of Heritable Infant Epilepsy Due To Mutations In The PRRT2 Gene
Australian researchers have discovered that variations in the PRRT2 gene may be the cause of some infantile seizures.
Study Finds Bidirectional Relationship Between Schizophrenia & Epilepsy
A study has shown a strong relationship between schizophrenia and epilepsy, suggesting a shared susceptibility between the diseases that may be a result of genetic, environmental, or neurobiological causes.
